Contro le vaccinazioni di massa forzate

La conferma della presenza dello squalene, degli effetti collaterali,della volontà di vaccinare due volte..

Focetria Link: http://www.emea.europa.eu/humandocs/PDFs/EPAR/focetria/Focetria-PU-05-en.pdf
Pandemrix Lonk: http://www.emea.europa.eu/humandocs/PDFs/EPAR/pandemrix/Pandemrix-PU-17-en.pdf

La conferma della presenza dello squalene, degli effetti collaterali,
della volontà di vaccinare due volte..

After mixing, 1 dose (0.5 ml) contains:
Split influenza virus inactivated, containing antigen equivalent to:
3.75 micrograms*
A/California/7/2009 (H1N1)v-like strain (X-179A)
AS03 adjuvant composed of squalene, DL-a-tocopherol and polysorbate 80
* haemagglutinin
3. LIST OF EXCIPIENTS
Polysorbate 80
Octoxynol 10
Thiomersal
Sodium chloride (NaCl)
Disodium hydrogen phosphate (Na2HPO4)
Potassium dihydrogen phosphate (KH2PO4)
Potassium chloride (KCl)
Magnesium chloride (MgCl2)
Water for injections

--------------------------------------------------

Influenza virus surface antigens (haemagglutinin and neuraminidase)* of strain:
A/California/7/2009 (H1N1)v like strain (X-179A) 7.5 micrograms** per 0.5 ml dose
* propagated in eggs
** expressed in microgram haemagglutinin.
Adjuvant MF59C.1 containing:
squalene 9.75 milligrams
polysorbate 80 1.175 milligrams
sorbitan trioleate 1.175 milligrams
This vaccine complies with the WHO recommendations and EU decision for the pandemic.
For a full list of excipients, see section 6.1.

-------------------------------